Xeris Biopharma Holdings Inc (XERS)
3.09
+0.05
(+1.64%)
USD |
NASDAQ |
Nov 22, 16:00
3.085
0.00 (0.00%)
After-Hours: 20:00
Xeris Biopharma Holdings Stock Buybacks (Quarterly): 0.083M for Sept. 30, 2024
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.083M |
| June 30, 2024 | 0.051M |
| March 31, 2024 | 3.434M |
| December 31, 2023 | 0.049M |
| September 30, 2023 | 0.072M |
| June 30, 2023 | 0.025M |
| March 31, 2023 | 0.863M |
| December 31, 2022 | 0.021M |
| September 30, 2022 | 0.028M |
| June 30, 2022 | 0.003M |
| March 31, 2022 | -29.58M |
| December 31, 2021 | 0.169M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -26.64M |
| Date | Value |
|---|---|
| December 31, 2020 | 0.00 |
| September 30, 2020 | -3.019M |
| June 30, 2020 | -20.13M |
| March 31, 2020 | -42.68M |
| December 31, 2019 | -1.722M |
| September 30, 2019 | 0.00 |
| June 30, 2019 | -3.895M |
| March 31, 2019 | -56.08M |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | -98.32M |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-42.68M
Minimum
Mar 2020
3.434M
Maximum
Mar 2024
-5.948M
Average
0.012M
Median
Stock Buybacks (Quarterly) Benchmarks
| Zevra Therapeutics Inc | -64.67M |
| NovaBay Pharmaceuticals Inc | -2.858M |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -0.004M |
| Theriva Biologics Inc | -3.716M |